Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 9211
TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449871BDBM449871(US10703741, Compound I-14)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449859BDBM449859(US10703741, Compound I-2)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449859BDBM449859(US10703741, Compound I-2)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449861BDBM449861(US10703741, Compound I-9 | US10703741, Compound I-...)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449862BDBM449862(US10703741, Compound I-5)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449872BDBM449872(US10703741, Compound I-15)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449871BDBM449871(US10703741, Compound I-14)
Affinity DataIC50: 5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449858BDBM449858(US10703741, Compound I-1)
Affinity DataIC50: 5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449858BDBM449858(US10703741, Compound I-1)
Affinity DataIC50: 5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449861BDBM449861(US10703741, Compound I-9 | US10703741, Compound I-...)
Affinity DataIC50: 5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449862BDBM449862(US10703741, Compound I-5)
Affinity DataIC50: 5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449865BDBM449865(US10703741, Compound I-8)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449865BDBM449865(US10703741, Compound I-8)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449860BDBM449860(US10703741, Compound I-3)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449861BDBM449861(US10703741, Compound I-9 | US10703741, Compound I-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449860BDBM449860(US10703741, Compound I-3)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449874BDBM449874(US10703741, Compound I-17)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449873BDBM449873(US10703741, Compound I-16)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449869BDBM449869(US10703741, Compound I-12)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449870BDBM449870(US10703741, Compound I-13)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449867BDBM449867(US10703741, Compound I-10)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449868BDBM449868(US10703741, Compound I-11)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449867BDBM449867(US10703741, Compound I-10)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449864BDBM449864(US10703741, Compound I-7)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449863BDBM449863(US10703741, Compound I-6)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449861BDBM449861(US10703741, Compound I-9 | US10703741, Compound I-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent